Omni Klentaq outperforms competitors in up to 15% blood.
Comparison of whole blood PCR results targeting CCR5 gene, 1.1 kb target. Omni Klentaq performs at blood percentages of 0, 5, and 15 percent while competitors A and B only perform at 0 percent.
Comparison of whole blood PCR results targeting Dystrophin gene, 0.32 kb target. Omni Klentaq performs at blood percentages of 0, 5, and 15 percent while competitors A and B only perform at 0 percent.